GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (OSTO:HNSA) » Definitions » FCF Yield %

Hansa Biopharma AB (OSTO:HNSA) FCF Yield % : -26.75 (As of May. 24, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hansa Biopharma AB FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Hansa Biopharma AB's Trailing 12-Month Free Cash Flow is kr-736.8 Mil, and Market Cap is kr2,589.0 Mil. Therefore, Hansa Biopharma AB's FCF Yield % for today is -26.75%.

The historical rank and industry rank for Hansa Biopharma AB's FCF Yield % or its related term are showing as below:

OSTO:HNSA' s FCF Yield % Range Over the Past 10 Years
Min: -62.89   Med: -3.99   Max: -0.77
Current: -26.75


During the past 13 years, the highest FCF Yield % of Hansa Biopharma AB was -0.77%. The lowest was -62.89%. And the median was -3.99%.

OSTO:HNSA's FCF Yield % is ranked worse than
64.99% of 1554 companies
in the Biotechnology industry
Industry Median: -14.35 vs OSTO:HNSA: -26.75

Hansa Biopharma AB's FCF Margin % for the quarter that ended in Mar. 2024 was -338.08%.


Hansa Biopharma AB FCF Yield % Historical Data

The historical data trend for Hansa Biopharma AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansa Biopharma AB FCF Yield % Chart

Hansa Biopharma AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.08 -2.72 -12.24 -19.61 -54.78

Hansa Biopharma AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.88 -31.96 -42.76 -50.01 -49.39

Competitive Comparison of Hansa Biopharma AB's FCF Yield %

For the Biotechnology subindustry, Hansa Biopharma AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hansa Biopharma AB's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hansa Biopharma AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Hansa Biopharma AB's FCF Yield % falls into.



Hansa Biopharma AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Hansa Biopharma AB's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-755.938 / 1380.00116
=-54.78%

Hansa Biopharma AB's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-189.259 * 4 / 1532.74938
=-49.39%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hansa Biopharma AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Hansa Biopharma AB FCF Yield % Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hansa Biopharma AB (OSTO:HNSA) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, 223 63
Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB (OSTO:HNSA) Headlines

No Headlines